Literature DB >> 7993642

Management of early breast cancer in southeast Netherlands since 1984. A population-based study. Regional Breast Cancer Study Group.

A C Voogd1, M W van Beek, M A Crommelin, H M Kluck, O J Repelaer van Driel, J W Coebergh.   

Abstract

We studied changes in staging and treatment of patients with early breast cancer (TNM stage I and II) in eight community hospitals in southeast Netherlands between 1984 and 1991 and related these changes to the guidelines for the management of breast cancer drawn up by the regional Breast Cancer Study Group. Since 1984, the proportion of patients that underwent breast-conserving therapy (local tumour excision, axillary dissection, and irradiation of the breast) increased from 26% to 53%. Although the mean number of axillary lymph nodes examined by the pathologists increased significantly, the proportion of patients with positive lymph nodes remained unchanged. The proportion of patients with involved axillary nodes receiving any form of adjuvant systemic therapy increased from 49% to 82%. Therapeutic policy initially varied significantly from one hospital to another but gradually became more uniform. We conclude that, except for elderly patients, treatment of early breast cancer corresponded increasingly to the guidelines of the regional Breast Cancer Study Group.

Entities:  

Mesh:

Year:  1994        PMID: 7993642     DOI: 10.3109/02841869409083944

Source DB:  PubMed          Journal:  Acta Oncol        ISSN: 0284-186X            Impact factor:   4.089


  4 in total

1.  Quality of adjuvant CMF chemotherapy for node-positive primary breast cancer: a population-based study.

Authors:  Michael Schaapveld; Elisabeth G E de Vries; Winette T A van der Graaf; Renée Otter; Pax H B Willemse
Journal:  J Cancer Res Clin Oncol       Date:  2004-07-16       Impact factor: 4.553

2.  Guideline adherence for early breast cancer before and after introduction of the sentinel node biopsy.

Authors:  M Schaapveld; E G E de Vries; R Otter; J de Vries; W V Dolsma; P H B Willemse
Journal:  Br J Cancer       Date:  2005-09-05       Impact factor: 7.640

3.  The impact of adjuvant therapy on contralateral breast cancer risk and the prognostic significance of contralateral breast cancer: a population based study in the Netherlands.

Authors:  Michael Schaapveld; Otto Visser; W J Louwman; Pax H B Willemse; Elisabeth G E de Vries; Winette T A van der Graaf; Renée Otter; Jan Willem W Coebergh; Flora E van Leeuwen
Journal:  Breast Cancer Res Treat       Date:  2007-08-09       Impact factor: 4.872

4.  Trends in the usage of adjuvant systemic therapy for breast cancer in the Netherlands and its effect on mortality.

Authors:  M M Vervoort; G Draisma; J Fracheboud; L V van de Poll-Franse; H J de Koning
Journal:  Br J Cancer       Date:  2004-07-19       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.